Fund Management at Engine No 1’s Regeneron Pharmaceuticals REGN Stock Holding History

Fund Management at Engine No 1’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,527	Closed	-$1.26M	–	333
2023 Q3	$1.26M	Buy	1,527 +123	+9%	+$96.7K	0.19%	106
2023 Q2	$1.01M	Buy	1,404 +100	+8%	+$77.1K	0.19%	118
2023 Q1	$1.07M	Buy	1,304 +125	+11%	+$94.3K	0.22%	101
2022 Q4	$851K	Buy	1,179 +149	+14%	+$110K	0.21%	111
2022 Q3	$710K	Sell	1,030 -61	-6%	-$38.4K	0.21%	104
2022 Q2	$645K	Buy	1,091 +187	+21%	+$122K	0.17%	130
2022 Q1	$631K	Buy	+904	New	+$572K	0.16%	131

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fund Management at Engine No 1's REGN Position: Q4 2023 in Review

Fund Management at Engine No 1 sold out of Regeneron Pharmaceuticals (REGN) in Q4 2023, closing a stake of 1,527 shares — an estimated $1.26M sold.

Fund Management at Engine No 1 first reported a position in REGN in Q1 2022 and held it in 7 quarters. The position peaked at $1.26M in Q3 2023. 1,272 funds tracked by Wall St. Rank hold REGN as of Q4 2023.

Fund Management at Engine No 1 reported no remaining Regeneron Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Fund Management at Engine No 1 sold 1,527 Regeneron Pharmaceuticals shares in Q4 2023, an estimated $1.26M.
Fund Management at Engine No 1 first reported a position in Regeneron Pharmaceuticals in Q1 2022 and held it in 7 quarters.
Fund Management at Engine No 1's Regeneron Pharmaceuticals position peaked at $1.26M in Q3 2023.
1,272 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2023.

Based on Fund Management at Engine No 1's 13F filing for Q4 2023.